Home » Newsletters » BioWorld Science

BioWorld Science

June 4, 1997

View Archived Issues

Scios licenses BNP technology to Abbott

Trega Biosciences and Chiroscience collaborate on cell adhesion inhibitors

U. of California discloses mammalian EPO-BP

Anti E- and P-selectin antibodies from PDL

NEP/ACE/ECE inhibitors described by Wakamoto

NeoRx reaches milestone in Biostent development

Preclinical and clinical data support use of cerebrocrast as neuroprotectant

State University of New York grants license to Noven for anticavity compounds

Shaman issued U.S. patents for type II diabetes compounds

Update on HIV research at Sheffield

Shire & Janssen acquire rights to Nivalin

Banyu developing new anticancer agent

New C5a antagonist discovered by Rhone-Poulenc Rorer

Dura signs collaboration agreements for Spiros inhalation system

Bristol-Myers Squibb selects diacid for development as antipsoriatic

Dual H1 and CysLT1 antagonist reported by Dutch and Japanese researchers

New analgesic under development by BioChem Pharma and Astra

New series for dementia from SIBIA Neurosciences

New MRI contrast agent from Nycomed

Basiliximab clinical data presented

Protein tyrosine kinase inhibition as antirejection therapy

Anti-TAC antibody prevents transplant rejection in phase III

Newly established Millennium BioTherapeutics enters therapeutic protein development collaboration

Mechanism of antiproliferative activity of SP-100030 defined

Dietary amino acids enhance allograft survival in rats

IL-10 pretreatment of transplant recipients prolongs allograft survival

Matrix Pharmaceutical's AccuSite recommended for approval in six European countries

Immunomedics' antibody therapy for non-Hodgkin's lymphoma shows promise in clinical trial

Genzyme and LeukoSite collaborate on autoimmune and inflammatory disease therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...